Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ILEVRO
- The PRIME Study: A Randomized, Controlled, Prospective Study
- Study Title: Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD With Extra (Pulse) Dose on Day of Surgery for Treatment of Ocular Inflammation Associated With Cataract Surgery
- Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
- Dropless vs. Standard Drops Contralateral Eye Study
- Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery
Clinical trials list
click for details